smith and nephew hip substitution

Smith and Nephew Inc was getting accused of violating Food and Drug Administration regulations when creating its hip replacement devices.

An FDA letter addressed to chairman John G.S. Buchanan dated Dec. 21 outlined violations at a manufacturing plant in Tuttlingen, Germany.

It was signed by the FDA’s Steven D. Silverman, director, Workplace of Compliance, Center for Devices and Radiological Health. The letter was posted to FDA’s site on Tuesday.

It indicates that correspondence among the business and the FDA has been on-going for some time. It outlines five places of corrective action.

Find out if you are eligible for a hip implant lawsuit